Shrikhande SV - Search Results

1

Efficacy and Safety of Sunitinib in Patients with Well-Differentiated Pancreatic Neuroendocrine Tumours.

Raymond E, Kulke MH, Qin S, Yu X, Schenker M, Cubillo A, Lou W, Tomasek J, Thiis-Evensen E, Xu JM, Croitoru AE, Khasraw M, Sedlackova E, Borbath I, Ruff P, Oberstein PE, Ito T, Jia L, Hammel P, Shen L, Shrikhande SV, Shen Y, Sufliarsky J, Khan GN, Morizane C, Galdy S, Khosravan R, Fernandez KC, Rosbrook B, Fazio N. Raymond E, et al. Among authors: shrikhande sv. Neuroendocrinology. 2018;107(3):237-245. doi: 10.1159/000491999. Epub 2018 Jul 10. Neuroendocrinology. 2018. PMID: 29991024

2

Pancreatic neuroendocrine tumors.

Shrikhande SV, Sirohi B, Goel M, Barreto SG. Shrikhande SV, et al. Indian J Gastroenterol. 2013 Jan;32(1):3-17. doi: 10.1007/s12664-012-0257-2. Epub 2012 Oct 3. Indian J Gastroenterol. 2013. PMID: 23054950 Review.

3

Regorafenib in gastrointestinal stromal tumors.

Sirohi B, Philip DS, Shrikhande SV. Sirohi B, et al. Among authors: shrikhande sv. Future Oncol. 2014;10(9):1581-7. doi: 10.2217/fon.14.101. Future Oncol. 2014. PMID: 25145429

4

Use of gemcitabine-platinum in Indian patients with advanced gall bladder cancer.

Sirohi B, Rastogi S, Singh A, Sheth V, Dawood S, Talole S, Ramadwar M, Kulkarni S, Shrikhande SV. Sirohi B, et al. Among authors: shrikhande sv. Future Oncol. 2015;11(8):1191-200. doi: 10.2217/fon.14.295. Future Oncol. 2015. PMID: 25832876

5

Neoadjuvant chemotherapy in patients with locally advanced gallbladder cancer.

Sirohi B, Mitra A, Jagannath P, Singh A, Ramadvar M, Kulkarni S, Goel M, Shrikhande SV. Sirohi B, et al. Among authors: shrikhande sv. Future Oncol. 2015;11(10):1501-9. doi: 10.2217/fon.14.308. Future Oncol. 2015. PMID: 25963427

6

Sunitinib in patients with imatinib-resistant gastrointestinal stromal tumor: A single center experience study.

Sahu A, Godbole S, Jain P, Ghosh J, Shrikhande S, Ramadwar M, Goyal M, Gulia S, Bajpai J, Kembhavi Y, Gupta S. Sahu A, et al. Indian J Cancer. 2015 Jul-Sep;52(3):320-3. doi: 10.4103/0019-509X.176747. Indian J Cancer. 2015. PMID: 26905126 Free article.

7

Treatment of patients with metastatic pancreatic cancer: Experience from a tertiary Indian cancer center.

Sirohi B, Dawood S, Rastogi S, Pandey A, Bal M, Shetty N, Shrikhande SV. Sirohi B, et al. Among authors: shrikhande sv. Indian J Cancer. 2015 Jul-Sep;52(3):449-52. doi: 10.4103/0019-509X.176732. Indian J Cancer. 2015. PMID: 26905166 Free article.

8

Nontrial, real-world outcomes in unresectable locally advanced pancreatic cancer: Chemotherapy and chemoradiation is the standard while surgery is uncommon.

Ramaswamy A, Jandyal S, Ostwal V, Engineer R, Lewis S, Bose S, Pande N, Shrikhande SV. Ramaswamy A, et al. Among authors: shrikhande sv. Indian J Cancer. 2017 Jul-Sep;54(3):530-534. doi: 10.4103/ijc.IJC_377_17. Indian J Cancer. 2017. PMID: 29798952 Free article.

9

Experience with non-cremophor-based paclitaxel-gemcitabine regimen in advanced pancreatic cancer: Results from a single tertiary cancer centre.

Ostwal V, Sahu A, Zanwar S, Nayak L, Shrikhande SV, Shetty N, Gupta S, Ramaswamy A. Ostwal V, et al. Among authors: shrikhande sv. Indian J Med Res. 2018 Sep;148(3):284-290. doi: 10.4103/ijmr.IJMR_249_17. Indian J Med Res. 2018. PMID: 30425218 Free PMC article.

10

Treatment practices for metastatic pancreatic cancer: Can we deliver an appropriately efficacious and safe regimen in Indian patients?

Ramaswamy A, Ostwal V, Goel A, Bhargava P, Srinivas S, Dsouza S, Shrikhande SV. Ramaswamy A, et al. Among authors: shrikhande sv. Indian J Cancer. 2018 Apr-Jun;55(2):138-143. doi: 10.4103/ijc.IJC_552_17. Indian J Cancer. 2018. PMID: 30604724 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

317 results

Search Page